Arvaya Healthcare Limited
BSE: BIJHANS · Trading & Distributors
Snapshot
Unlock Arvaya Healthcare Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Arvaya Healthcare Limited is an Indian public enterprise operating in the trading and distributors sector with a primary focus on healthcare and pharmaceuticals. The company engages in the distribution, marketing, and trading of diverse pharmaceutical formulations, healthcare products, and medical consumables to various institutional buyers and pharmacies.
Business Model
The company generates revenue by leveraging its distribution network to supply essential medicines and wellness products to healthcare providers, pharmacies, and institutional buyers. It acts as a reliable intermediary in the pharmaceutical distribution landscape, focusing on supply chain partnerships and quality standards.
Management Commentary
Management emphasizes maintaining stringent quality standards and expanding its robust supply chain partnerships to ensure efficient healthcare solution delivery across target markets.
Growth Outlook
Growth is expected to be driven by the expansion of its distribution network and increasing demand for essential medicines and medical consumables in its target markets.
Key Risks
- Supply Chain Disruption. Any interruption in the pharmaceutical supply chain or logistics network could adversely affect timely product delivery and operational performance.
- Regulatory Compliance. Changes in government regulations and pharmaceutical distribution standards may impact profit margins and operational compliance requirements.
- Competitive Pressure. Intense competition within the healthcare trading and distribution sector could exert downward pressure on margins and market share.
Start your research today
Unlock AI insights, financials, peers and live data on Arvaya Healthcare Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹0.10 Cr
TTM · standalone
NET PROFIT
₹-2 Cr
TTM · standalone
EPS
₹-1.44
TTM · standalone
RETURN ON EQUITY
-6.5%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
-6.0%
TTM · standalone
P/E
-59.5x
Q1 FY27 · standalone
EV/EBITDA
-349.3x
Q1 FY27 · standalone
Peers · Trading & Distributors
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Arvaya Healthcare LimitedBIJHANS | ₹644 Cr | -59.46 | -349.31 | -47.4% | -553.8% | -6.5% | -6.0% | +191.1% |
The Yamuna Syndicate LtdYSL | ₹808 Cr | 8.74 | 177.28 | 11.3% | 6.3% | 7.1% | 0.3% | -27.9% |
Riddhi Siddhi Gluco Biols LtdRIDDHI | ₹706 Cr | -29.36 | 17.69 | -38.0% | 29.1% | -1.1% | 2.4% | +28.0% |
Shiv Aum SteelsSHIVAUM | ₹698 Cr | — | — | — | 2.8% | — | — | — |
The State Trading Corporation of India LimitedSTCINDIA | ₹672 Cr | 0.99 | 14.92 | — | -477.0% | 225.0% | 229.6% | -20.2% |
SMT EngineeringSMTEL | ₹612 Cr | 22.66 | 15.73 | 248.1% | 26.5% | 26.8% | 35.5% | +429.2% |
As of Q1 FY27
Financials
Arvaya Healthcare Limited
BSE: BIJHANS · Trading & Distributors
Snapshot
Unlock Arvaya Healthcare Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Arvaya Healthcare Limited is an Indian public enterprise operating in the trading and distributors sector with a primary focus on healthcare and pharmaceuticals. The company engages in the distribution, marketing, and trading of diverse pharmaceutical formulations, healthcare products, and medical consumables to various institutional buyers and pharmacies.
Business Model
The company generates revenue by leveraging its distribution network to supply essential medicines and wellness products to healthcare providers, pharmacies, and institutional buyers. It acts as a reliable intermediary in the pharmaceutical distribution landscape, focusing on supply chain partnerships and quality standards.
Management Commentary
Management emphasizes maintaining stringent quality standards and expanding its robust supply chain partnerships to ensure efficient healthcare solution delivery across target markets.
Growth Outlook
Growth is expected to be driven by the expansion of its distribution network and increasing demand for essential medicines and medical consumables in its target markets.
Key Risks
- Supply Chain Disruption. Any interruption in the pharmaceutical supply chain or logistics network could adversely affect timely product delivery and operational performance.
- Regulatory Compliance. Changes in government regulations and pharmaceutical distribution standards may impact profit margins and operational compliance requirements.
- Competitive Pressure. Intense competition within the healthcare trading and distribution sector could exert downward pressure on margins and market share.
Start your research today
Unlock AI insights, financials, peers and live data on Arvaya Healthcare Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹0.10 Cr
TTM · standalone
NET PROFIT
₹-2 Cr
TTM · standalone
EPS
₹-1.44
TTM · standalone
RETURN ON EQUITY
-6.5%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
-6.0%
TTM · standalone
P/E
-59.5x
Q1 FY27 · standalone
EV/EBITDA
-349.3x
Q1 FY27 · standalone
Peers · Trading & Distributors
As of Q1 FY27